Abstract
Orally bioavailable anticoagulants are needed that exhibit rapid and predictable onset and offset kinetics. This study was designed to determine whether maltodapoh, a novel sulfated bis-maltobionic acid amide, exhibits anticoagulant and antithrombotic activity in vivo after oral administration. Maltodapoh exhibited a dose-dependent increase in activated partial thromboplastin time (aPTT) in both rabbit and human plasma in vitro. Maltodapoh also induced a dose-dependent increase in aPTT when administered either i.v. or p.o. in rabbits. After a single oral bolus (3 mg/kg), aPTT increased 2- to 3-fold between 4 and 8 h and remained elevated for at least 24 h. This dose doubled the time to the onset of thrombotic occlusion after electrical injury to the carotid artery (from 52 ± 12 min in vehicle-treated, control rabbits, n = 7, to 98 ± 12 min in maltodapoh-treated animals, n = 7,P < .001) and reduced by 84% the weight of thrombus in the superior vena cava induced over 2 h after insertion of a thrombogenic copper wire and thread device (from 37 ± 10 mg in controls to 6 ± 3 mg in maltodapoh-treated animals,P < .001). Thus, based on the in vivo activity after oral administration, favorable kinetic profile and efficacy for inhibition of both arterial and venous thrombosis, further testing of this class of compounds appears warranted.
Footnotes
-
Send reprint requests to: Dr. Dana R. Abendschein, Cardiovascular Division, Washington University School of Medicine, 660 South Euclid Avenue, Box 8086, St. Louis, MO 63110.
-
↵1 This work was supported by Grants HL-53460 (D.R.A.) and HL-55520 (D.M.T.) from the National Institutes of Health and a grant from Reliable Biopharmaceuticals.
- Abbreviations:
- aPTT
- activated partial thromboplastin time
- PBS
- phosphate-buffered saline
- HPLC
- high-pressure liquid chromatography
- HCII
- heparin cofactor II
- ATIII
- antithrombin III
- Received March 23, 1998.
- Accepted July 13, 1998.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|